Cargando…
Compensation for cures: Why we should pay a premium for participation in ‘challenge studies’
Antibiotic resistance is one of the most pressing public health problems humanity faces. Research into new classes of antibiotics and new kinds of treatments – including risky experimental treatments such as phage therapy and vaccines – is an important part of improving our ability to treat infectio...
Autores principales: | Anomaly, Jonathan, Savulescu, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773221/ https://www.ncbi.nlm.nih.gov/pubmed/31135070 http://dx.doi.org/10.1111/bioe.12596 |
Ejemplares similares
-
The international dimensions of antimicrobial resistance: Contextual factors shape distinct ethical challenges in South Africa, Sri Lanka and the United Kingdom
por: Krockow, Eva M., et al.
Publicado: (2019) -
How law can help solve the collective action problem of antimicrobial resistance
por: Hoffman, Steven J., et al.
Publicado: (2019) -
Antibiotic resistance as a tragedy of the commons: An ethical argument for a tax on antibiotic use in humans
por: Giubilini, Alberto
Publicado: (2019) -
Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021) -
2530: Should all clinical research subjects pay the same?
por: McKinney, Bernadette
Publicado: (2018)